|
Having trouble viewing this email? View it as a Web page.
Today the U.S. Centers for Disease Control and Prevention published “Update to CDC’s Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections,” in Morbidity and Mortality Weekly Report. The most significant change to the new guidelines is that CDC no longer recommends an exclusively oral treatment regimen for gonorrhea. CDC now recommends a dual therapy of injectable ceftriaxone in combination with a second antibiotic. Ceftriaxone is more potent against gonorrhea than the once recommended oral antibiotic cefixime and, when paired with the additional oral antibiotic, might slow the emergence of drug resistance by ensuring that gonorrhea infections are quickly cured. The changes to the gonorrhea treatment guidelines affect how we practice public health. Please visit the STD Treatment web page for more information about the treatment changes. A variety of supplemental resources were also developed to accompany the updated guidelines. Update to CDC's Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral Cephalosporins No Longer a Recommended Treatment for Gonococcal Infections published in the August 10, 2012 issue of MMWR.
Updated Gonorrhea Clinical Training:
Banners & Graphics -- Promote STD prevention and link to the updated gonorrhea treatment guidelines by placing banners on your website. Thank you for your commitment to STD prevention. Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates To receive the latest news for your region, please update your profile with your country, state and zip code. Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
|
||||||||||||||||||||||||||||||||||
